SCHEMBL19986457

SCHEMBL19986457

Cc1cc(NC(=O)NC2CCCCC2Nc2c(C)cncc2C)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.47
RAB9A P51151 9/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDR P35968 1/20 0.44
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
EPHX2 P34913 1/20 0.42
BLM P54132 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 1/20 0.42
SSTR3 P32745 1/20 0.41
CCR3 P51677 1/20 0.40
EPHX1 P07099 2/20 0.39
KCNJ6 P48051 2/20 0.39
KCNJ5 P48544 2/20 0.39
KCNJ3 P48549 2/20 0.39
GAA P10253 1/20 0.39
FPR1 P21462 1/20 0.39
FPR2 P25090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986636 0.93 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KDRTSHR
SCHEMBL28629552 0.80 KMT2A (0.59) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL28630091 0.80 KMT2A (0.59) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL19986632 0.80 KMT2A (0.59) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL19986449 0.80 NPC1 (0.56) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL19986659 0.80 KMT2A (0.59) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL19986451 0.80 NPC1 (0.56) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL19986586 0.80 KMT2A (0.59) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL28626555 0.78 SSTR3 (0.50) NPC1RAB9ASMN1; SMN2TSHRHTT
SCHEMBL19986702 0.78 SSTR3 (0.50) NPC1RAB9ASMN1; SMN2TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018050110-A1 NOVEL CAPSID PROTEIN ASSEMBLY INHIBITOR 正大天晴药业集团股份有限公司 2018-03-22 WO disclosed